Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 7, 1997, Pages 1967-1975

  Baxter, G F ^a   Mocanu, M M ^b   Yellon, D M ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

1,2 dioctanoyl sn glycerol; Diacylglycerol; Infarct size; Ischaemia reperfusion; Ischaemic preconditioning; Protein kinase C (PKC); Second window of protection

Indexed keywords

CHELERYTHRINE; DIACYLGLYCEROL; DIOCTANOIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; BLOOD PRESSURE; DIGLYCERIDES; ENZYME ACTIVATION; HEART RATE; HEAT-SHOCK PROTEINS; HEMODYNAMIC PROCESSES; HYDROGEN-ION CONCENTRATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROTEIN KINASE C; RABBITS; REPERFUSION INJURY; TIME FACTORS;

EID: 0031194233     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0436     Document Type: Article

References (33)

1. BAXTER GF, MARBER MS, PATEL VC, YELLON DM, 1994. Adenosine receptor involvement in a delayed phase of protection 24 hours following ischemic preconditioning. Circulation 90: 2993-3000.
2. BAXTER GF, GOMA FM, YELLON DM, 1995. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 115: 222-224.
3. BAXTER GF, MOCANU MM, YELLON DM, 1996. Diacylglycerol treatment in vivo increases ischaemic tolerance 24 h later in a rabbit model of myocardial infarction. J Mol Cell Cardiol 28: A19 (abstract).
4. BOGOYEVITCH MA, GILLESPIE-BROWN J, KETTERMAN AJ, FULLER SJ, BEN-LEVY R, ASHWORTH A, MARSHALL CJ, SUGDEN PH, 1996. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173.
5. 2+ in adult rat cardiac myocytes. Circ Res 66: 1143-1155.
6. CHUANG M, SEVERSON DL, 1990. Inhibition of diacylglycerol metabolism in isolated cardiac myocytes by U-57 908 (RHC 80267), a diacylglycerol lipase inhibitor. J Mol Cell Cardiol 22: 1009-1016.
7. CONFORTI L, SUMII K, SPERELAKIS N, 1995. Dioctanoylglycerol inhibits L-type calcium current in embryonic chick cardiomyocytes independent of protein kinase C activation. J Mol Cell Cardiol 27: 1219-1224.
8. EDES I, KRANIAS EG, 1990a. The effects of phorbol esters and diacylglycerol analogues on the basal phosphoinositide turnover in isolated guinea pig hearts. Cardioscience 1: 265-274.
9. EDES I, KRANIAS EG, 1990b. Phospholamban and troponin I are substrates for protein kinase C in vitro but not in intact beating guinea pig hearts. Circ Res 67: 394-400.
10. FAUCHER C, CAPDEVIELLE J, CANAL I, FERRAR P, MAZARGUIL H, MCGUIRE WL, DARBON J-M, 1993. The 28-kDa protein whose phosphorylation is induced by protein kinase C activators in MCF-7 cells belongs to the family of low molecular mass heat shock proteins and is the estrogen-regulated 24-kDa protein. J Biol Chem 268: 15168-15173.
11. GERWINS P, FREDHOLM BB, 1995. Activation of adenosine A1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cells. Naunyn-Schmeideberg's Arch Pharmacol 351: 186-193.
12. HEADS RJ, LATCHMAN DS, YELLON DM, 1996a. The molecular basis of adaptation to ischemia in the heart: the role of stress proteins and anti-oxidants in the ischemic and reperfused heart. In: Karmazyn M (ed.). Myocardial Ischemia: Mechanisms, Reperfusion, Protection. Basle: Birkhauser Verlag, 383-407.
13. HEADS RJ, LATCHMAN DS, YELLON DM, 1996b. HSP expression and protection after heat stress in myogenic cells, and after simulated ischemia in cardiomyocytes, are protein kinase C-dependent. Circulation 94 (Suppl. I): I-423 (abstract).
14. HEE-CHEONG M, SEVERSON DL, 1989. Metabolism of dioctanoylglycerol by isolated cardiac myocytes. J Mol Cell Cardiol 21: 829-837.
15. HERBERT JM, AUGEREAU JM, GLEYE J, MAFFRAND JP, 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Comm 172: 993-999.
16. IMAGAWA J, BAXTER GF, YELLON DM, 1997. Genistein, a tyrosine kinase inhibitor, blocks the second window of protection 48 hours after ischaemic preconditioning. J Mol Cell Cardiol 29: 1885-1893.
17. ISSANDOU M, DARBON J-M, 1991. Activation of protein kinase C by phorbol esters induces DNA synthesis and protein phosphorylation in glomerular mesangial cells. FEBS Lett 281: 196-206.
18. KNIGHT RJ, BUXTON DB, 1996. Stimulation of c-jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Comm 218: 83-88.
19. KUZUYA T, HOSHIDA S, YAMASHITA N, FUJI H, OE H, HORI M, KAMADA T, TADA M, 1993. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299.
20. MARBER MS, YELLON DM, 1994. Hsp70 in myocardial ischemia. Experientia 50: 1075-1084.
21. MARBER MS, LATCHMAN DS, WALKER JM, YELLON DM, 1993. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272.
22. MARTIN JL, MESTRIL R, HICKEY E, 1995. HSP27 and protection against ischemic damage. J Mol Cell Cardiol 27: A20 (abstract).
23. 1-adrenoceptors and protein synthesis. J Mol Cell Cardiol 28: 2017-2025.
24. MESTRIL R, DILLMANN WH, 1995. Heat shock proteins and protection against myocardial ischemia. J Mol Cell Cardiol 27: 45-52.
25. MURRY CE, JENNINGS RG, REIMER KA, 1986. Preconditioning with ischemia: a delay in lethal injury in ischemic myocardium. Circulation 74: 1124-1136.
26. ORTON EC, RAFFESTIN B, MCMURTRY IF, 1990. Protein kinase C influences rat pulmonary vascular reactivity. Am Rev Resp Dis 141: 654-658.
27. SPEECHLY-DICK ME, MOCANU MM, YELLON DM, 1994. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 75: 586-590.
28. TEUTSCH I, WEIBLE A, SIESS M, 1987. Differential inotropic and chronotropic effects of various protein kinase C activators on isolated guinea pig atria. Eur J Pharmacol 144: 363-367.
29. VAN WINKLE DM, THORNTON JD, DOWNEY DM, DOWNEY JM, 1991. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Cor Art Dis 2: 613-619.
30. YAMASHITA N, KUZUYA T, HOSHIDA S, NISHIDA M, IGARISHI J, HORI M, KAMADA T, TADA M, 1995. A "second window of protection" occurs 24 hours after ischemic preconditioning in rat heart. J Mol Cell Cardiol 27: A517 (abstract).
31. YELLON DM, BAXTER GF, 1995. A second window of protection or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034.
32. YTREHUS K, LIU Y, DOWNEY JM, 1994. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152.
33. YUAN SH, SUNAHARA FA, SEN AK, 1987. Tumor-promoting phorbol esters inhibit cardiac functions and induce redistribution of protein kinase C in perfused beating rat heart. Circ Res 61: 372-378.